Paul J. Rowe

Effect of Dupilumab on Blood Eosinophil Counts in Patients With Asthma, Chronic Rhinosinusitis With Nasal Polyps, Atopic Dermatitis, or Eosinophilic Esophagitis

Michael E. Wechsler, Amy D. Klion, Pierluigi Paggiaro et al. · The Journal of Allergy and Clinical Immunology In Practice · 2022 · 229 citations · Full text

Medicine, Immunology, Pharmacology +17

Baseline FeNO Independently Predicts the Dupilumab Response in Patients With Moderate-to-Severe Asthma

Ian Pavord, Yamo Deniz, Jonathan Corren et al. · The Journal of Allergy and Clinical Immunology In Practice · 2022 · 89 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Effect of dupilumab on exhaled nitric oxide, mucus plugs, and functional respiratory imaging in patients with type 2 asthma (VESTIGE): a randomised, double-blind, placebo-controlled, phase 4 trial

Mario Castro, Alberto Papi, Celeste Porsbjerg et al. · The Lancet Respiratory Medicine · 2025 · 67 citations · Full text

Medicine, Clinical Sciences, Pharmacology +16

Dupilumab Demonstrates Rapid Onset of Response Across Three Type 2 Inflammatory Diseases

Giorgio Walter Canonica, Arnaud Bourdin, Anju T. Peters et al. · The Journal of Allergy and Clinical Immunology In Practice · 2022 · 53 citations · Full text

Medicine, Dermatology, Pharmacotherapy +16

Dupilumab Reduces Oral Corticosteroid Use in Patients With Corticosteroid-Dependent Severe Asthma

Lawrence Sher, Michael E. Wechsler, Klaus F. Rabe et al. · CHEST Journal · 2022 · 44 citations · Full text

Pharmacy, Immunology, Pharmacology +11